Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000551707 | SCV000652018 | likely pathogenic | Charcot-Marie-Tooth disease axonal type 2P | 2019-07-16 | criteria provided, single submitter | clinical testing | This sequence change affects an acceptor splice site in intron 17 of the LRSAM1 gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. This variant is present in population databases (rs747659617, ExAC 0.2%). This variant has not been reported in the literature in individuals with LRSAM1-related conditions. Donor and acceptor splice site variants typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in LRSAM1 are known to be pathogenic (PMID: 20865121). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |